The sight test fee Effectiveness for treatment for glaucoma remains unproved

BMJ 1994; 309 doi: 10.1136/bmj.309.6965.1369b (Published 19 November 1994)
Cite this as: BMJ 1994;309:1369.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. L Clearkin
  1. Arrowe Park Hospital, Upton, Wirral, Merseyside L49 5PE

    EDITOR, - D A H Laidlaw and colleagues are concerned that the prevalence of blindness due to glaucoma may increase because of reduced uptake of screening since the introduction of the sight test fee.1 Their implication is that treatment …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL